Carcinoembryonic Antigen (CEA) Market worth over $2.7bn by 2023: Global Market Insights Inc. Carcinoembryonic Antigen (CEA) Market size is driven by increasing incidence rate for cancer disease especially colorectal cancer is one of the important factor contributing to the growth. Global Carcinoembryonic Antigen Market is set to register profitable growth in the near future and surpass USD 2.8 billion by 2023. This growth is attributed to factors including consistent technology advancements, development of novel biomarkers and growing prevalence of cancer. Global Market Insights, Inc. announces the addition of a new research report on Carcinoembryonic Antigen (CEA) market to their offering. The report gives you a basic overview of the CEA market with market definition, applications, segmentation, and value chain analysis. The report covers competitive landscape with the leading company profiles and recent events in the industry. Equipped with all vital information including current scenario, forecasts, and future predictions, it offers insights to foresee challenges and opportunities that will aid in making informed decisions.
Growing demand for minimally invasive diagnostics procedures is projected to contribute a significant part in shaping market growth. Increasing geriatric population is another key factor to intensify the Carcinoembryonic Antigen market growth. The development of novel combination biomarkers and initiatives by the government concerning improved diagnostic rates are likely to open growth avenues for CEA market. The advent of various tumor markers, which can be used along with CEA to monitor or diagnose colorectal cancer is predicted to influence the market growth positively. North America, hinged on the U.S. Carcinoembryonic Antigen market size, is predicted to lead the segment with estimations of USD 800 million in 2016. Growing awareness about detecting cancer at an early stage and improved health care services for cancer therapeutics are anticipated to propel growth. Asia-Pacific region driven by India and China is targeted to foresee growing prevalence of cancer owing to changes in lifestyle and aging population in the area. The growth is mainly attributed to improved treatment facilities and high disposable income. The AsiaPacific market share can surpass USD 380 million in the near future. Colorectal cancer tops the application segment and is expected to foresee growth over the forecast period. Breast cancer segment is likely to be the most lucrative with 1|Page
estimations of over USD 460 million at over 7% CAGR during the projected time frame.
Germany Carcinoembryonic Antigen (CEA) Market size, by application, 20122023 (USD Million)
To access sample pages or view this report titled, “Carcinoembryonic Antigen (CEA) Market Size By Application (Colorectal, Pancreatic, Ovarian, Breast, Thyroid Cancer], Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, France, Spain, Japan, China, India, Mexico, Brazil, South Africa), Application Potential, Competitive Market Share & Forecast, 2016 – 2023” in detail along with the table of contents, please click on the link below: https://www.gminsights.com/industry-analysis/carcinoembryonic-antigen-cea-marketreport The key players in global carcinoembryonic antigen market include: • • • •
Quest Diagnostics Roche Diagnostics GenWay Biotech, Inc. Abbott Diagnostics
2|Page
Focus on early detection methods and product innovation owing to rising demand for minimally invasive procedures is a key strategy adopted by the key participants in the market.
Table of Content of Carcinoembryonic Antigen Market: Chapter 1. 1.1.
Methodology and Scope Research Methodology
1.1.1.
Initial data exploration
1.1.2.
Statistical model and forecast
1.1.3.
Industry insights and validation
1.1.4.
Research scope & assumptions
1.2.
Data Sources 1.2.1. Primary Sources 1.2.2. Secondary Sources
Chapter 2.
Executive Summary Carcinoembryonic antigen industry 3600 synopsis, 2012 - 2023
2.1.
2.1.1.
Business trends
2.1.2.
Application trends
2.1.3.
Regional trends
Chapter 3.
Carcinoembryonic antigen Industry Insights
3.1.
Industry segmentation
3.2.
Industry size and forecast, 2012 - 2023
3.3.
Industry impact forces 3.3.1.
Growth drivers 3.3.1.1.
3|Page
Growing elderly population base
3.3.2.
3.3.1.2.
Minimally invasive diagnostic procedure demand
3.3.1.3.
Increasing cancer prevalence
3.3.1.4.
Combination biomarker adoption surge
3.3.1.5.
Healthcare expenditure trends
3.3.1.6.
CEA usage in cancer
Industry pitfalls & challenges 3.3.2.1.
Complex regulatory landscape
3.3.2.2.
Ineffectiveness in detecting cancer at early stages
3.4.
Growth potential benchmarking
3.5.
Company market share analysis, 2015 3.5.1. Strategy dashboard
3.6.
Porter’s analysis
3.7.
PESTEL analysis
About Global Market Insights: Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology. Contact Us:
Arun Hegde Corporate Sales, USA Global Market Insights, Inc. Phone: 1-302-846-7766 Toll Free: 1-888-689-0688 Email: sales@gminsights.com 4|Page
Web: https://www.gminsights.com Blog: https://gminsights.wordpress.com Connect with us: Facebook | Google+ | LinkedIn | Twitter
5|Page